Cisa RSV infants study (contributing site)

Active Awarded Last action

Contract number
75D30124F00002
Awardee
Awarding agency
Obligated
$730,098

Award facts

Contract value 98% obligated
  • $730,098.00 Current, with exercised options
  • $741,949.00 Potential, with all options
Completion date 69% complete
Current and potential, with all options
NAICS code
611210 Junior Colleges
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $0
Other Administrative Action P00002 · EO 14398 $0
Original award $730,098

About this award

The Centers for Disease Control and Prevention issued a delivery order to Kaiser Foundation Hospitals on September 27, 2024, under the Clinical Immunization Safety Assessment 2023–2028 (CISA) IDIQ for research support as a contributing site to the CISA RSV infants study, with a ceiling value of $741,949.

The CISA IDIQ is an $86 million multiple-award vehicle through September 2028 supporting clinical immunization safety assessment work. Place of performance is Durham, NC. Performance runs through September 26, 2027. Work is structured as cost-no-fee, with Kaiser Foundation Hospitals self-performing the effort. Service Contract Inventory reporting for FY2025 reflects $5,000 invoiced with 0.0 FTEs, indicating early-stage engagement or staffing ramp-up against the order ceiling.

Quick answers

Who was awarded contract 75D30124F00002?

75D30124F00002 was awarded to Kaiser Foundation Hospitals by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 27, 2024.

How much is contract 75D30124F00002 worth?

The government has obligated $730,098 on 75D30124F00002. Its potential value, with all options, is $741,949.

Is contract 75D30124F00002 an order under another contract?

Yes. 75D30124F00002 is a delivery order under 75D30123D18250, an indefinite delivery contract, on Clinical Immunization Safety Assessment 2023 - 2028 (CISA).

Was contract 75D30124F00002 competed?

The extent of competition for 75D30124F00002 was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award